Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurotoxicity

22 Jan 2016

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurological diseases and metabolism
Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 26808467
DOI: 10.1016/j.jchemneu.2016.01.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurotoxicityPMID 26808467Read ↗

Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in miceSemantic proximity Read ↗

Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic miceSemantic proximity Read ↗

Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's diseaseSemantic proximity Read ↗

Recent Developments in LRRK2-Targeted Therapy for Parkinson’s DiseaseSemantic proximity Read ↗

G2019S-LRRK2 mutation enhances MPTP-linked Parkinsonism in mice.Semantic proximity Read ↗

Mouse models for LRRK2 Parkinson's diseaseSemantic proximity Read ↗

Modifiers of LRRK2 parkinsonism: new therapeutic targets.Semantic proximity Read ↗

LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson's disease in a Han Chinese population from Southern Mainland ChinaSemantic proximity Read ↗

Development of mutation-selective LRRK2 kinase inhibitors as precision medicine for Parkinson's disease and other diseases for which carriers are at increased riskSemantic proximity Read ↗

LRRK2 Promotes Tau Accumulation, Aggregation and ReleaseSemantic proximity Read ↗

LRRK2 mutations and neurotoxicant susceptibility.Semantic proximity Read ↗

The Discovery of LRRK2 Mutations as a Cause of Parkinson's Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.